Prediction of the human EP1 receptor binding site by homology modeling and molecular dynamics simulation

Scientia Pharmaceutica

Volumn 79, Issue 4, 2011, Pages 793-816

  Zare, Behnoush ^a   Madadkar Sobhani, Armin ^b   Dastmalchi, Siavoush ^c   Mahmoudian, Masoud ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Flexible ligand docking; G protein coupled receptors (GPCR); Homology modeling; Human prostanoid E1 receptor; Molecular dynamics simulation

Indexed keywords

ILOPROST; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E2; RHODOPSIN;

ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; HUMAN; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PREDICTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SIMULATION;

EID: 82055180466     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1106-24     Document Type: Article

References (63)

1. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: Structures, properties, and functions. Physiol Rev. 1999; 79: 1193-1226. http://www.ncbi.nlm.nih.gov/pubmed/10508233
2. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. Prostanoid receptors: Subtypes and signaling. Annu Rev Pharmacol Toxicol. 2001; 41: 661-690. http://dx.doi.org/10.1146/annurev.pharmtox.41.1.661
3. Boie Y, Stocco R, Sawyer N, Slipetz DM, Ungrin MD, Neuschafer-Rube F, Puschel GP, Metters KM, Abramovitz M. Molecular cloning and characterization of the four rat prostaglandin E-2 prostanoid receptor subtypes. Eur J Pharmacol.1997; 340: 227-241. http://dx.doi.org/10.1016/S0014-2999(97)01383-6
4. Kiriyama, M., Ushikubi, F., Kobayashi, T, Hirata, M, Sugimoto, Y, Narumiya, S. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol.1997; 122: 217-224. http://dx.doi.org/10.1038/sj.bjp.0701367
5. Zeilhofer HU. Prostanoids in nociception and pain. Biochem Pharmacol. 2007; 73: 165-174. http://dx.doi.org/10.1016/j.bcp.2006.07.037
6. Baldwin JM. The Probable Arrangement of the Helices in G-Protein-Coupled Receptors. EMBO J. 1993; 12: 1693-1703. http://www.ncbi.nlm.nih.gov/pubmed/8385611
7. Baldwin JM, Schertler GFX, Unger VM. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J Mol Biol. 1997; 272: 144-164. http://dx.doi.org/10.1006/jmbi.1997.1240
8. Reggio PH. Computational methods in drug design: Modeling G protein-coupled receptor monomers, dimers, and oligomers. AAPS J. 2006; 8: E322-E336. http://dx.doi.org/10.1208/aapsj080237
9. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science. 2000; 289: 739-745. http://dx.doi.org/10.1126/science.289.5480.739
10. Rasmussen SGF, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VRP, Sanishvili R, Fischetti RF, Schertler GFX, Weis WI, Kobilka BK. Crystal structure of the human beta(2) adrenergic G-protein-coupled receptor. Nature. 2007; 450: 383-387. http://dx.doi.org/10.1038/nature06325
11. Rasmussen SG, Choi HJ, Fung JJ, Pardon E, Casarosa P, Chae PS, Devree BT, Rosenbaum DM, Thian FS, Kobilka TS, Schnapp A, Konetzki I, Sunahara RK, Gellman SH, Pautsch A, Steyaert J, Weis WI, Kobilka BK. Structure of a nanobody-stabilized active state of the b2 adrenoceptor. Nature. 2011; 469: 175-180. http://dx.doi.org/10.1038/nature09648
12. Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, Hamel DJ, Kuhn P, Handel TM, Cherezov V, Stevens RC. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists. Science. 2010; 330: 1066-1071. http://dx.doi.org/10.1126/science.1194396
13. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res. 2000; 28: 235-242. http://dx.doi.org/10.1093/nar/28.1.235
14. Dastmalchi S, Church WB, Morris M. Modelling the structures of G protein-coupled receptors aided by three-dimensional validation. BMC Bioinformatics. 2008; 9 (Suppl 1): S14. http://dx.doi.org/10.1186/1471-2105-9-S1-S14
15. Hillisch A, Pineda LF, Hilgenfeld R. Utility of homology models in the drug discovery process. Drug Discov Today. 20047; 9: 659-669. http://dx.doi.org/10.1016/S1359-6446(04)03196-4
16. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AGW, Tate CG, Schertler GFX. Structure of a beta(1)-adrenergic G-protein-coupled receptor. Nature. 2008; 454: 486-491. http://dx.doi.org/10.1038/nature07101
17. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY T, Lane JR, Ijzerman AP, Stevens RC. The 2.6 Angstrom Crystal Structure of a Human A(2A) Adenosine Receptor Bound to an Antagonist. Science. 2008; 322: 1211-1217. http://dx.doi.org/10.1126/science.1164772
18. Wolf S, Böckmann M, Höweler U, Schlitter J, Gerwert K. Simulations of a G protein-coupled receptor homology model predict dynamic features and a ligand binding site. FEBS Lett. 2008; 582: 3335-3342. http://dx.doi.org/10.1016/j.febslet.2008.08.022
19. Zare B, Madadkar-Sobhani A, Dastmalchi S, Mahmoudian M. Modeling of the hEP1 receptor based on the crystallographic structure of beta(2)-adrenergic receptor and its assessment with docking studies and molecular dynamics simulation. Daru. 2009; 17: 299-307.
20. Costanzi S, Siegel J, Tikhonova IG, Jacobson KA. Rhodopsin and the others: a historical perspective on structural studies of G protein-coupled receptors. Curr Pharm Des. 2009; 15: 3994-4002. http://dx.doi.org/10.2174/138161209789824795
21. Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003; 31: 3784-3788. http://dx.doi.org/10.1093/nar/gkg563
22. Kabsch W, Sander C. Dictionary of protein secondary structure - pattern-recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983; 22: 2577-2637. http://dx.doi.org/10.1002/bip.360221211
23. Tusnady GE, Simon I. The HMMTOP transmembrane topology prediction server. Bioinformatics. 2001; 17: 849-850. http://dx.doi.org/10.1093/bioinformatics/17.9.849
24. Jones DT, Taylor WR, Thorton JM. A Model Recognition Approach to the Prediction of All-Helical Membrane-Protein Structure and Topology. Biochemistry. 1994; 33: 3038-3049. http://dx.doi.org/10.1021/bi00176a037
25. B. PHD: Predicting one-dimensional protein structure by profile-based neural networks Computer Methods for Macromolecular Sequence Analysis. Academic Press Inc, San Diego, 1996: 525-539.
26. Melen K, Krogh A, von Heijne G. Reliability measures for membrane protein topology prediction algorithms. J Mol Biol. 2003; 327: 735-744. http://dx.doi.org/10.1016/S0022-2836(03)00182-7
27. Claros MG, Vonheijne G. Toppred-II - an Improved Software for Membrane-Protein Structure Predictions. Comput Appl Biosci. 1994; 10: 685-686. http://dx.doi.org/10.1093/bioinformatics/10.6.685
28. Ouali M, King RD. Cascaded multiple classifiers for secondary structure prediction. Protein Sci. 2000; 9: 1162-1176. http://dx.doi.org/10.1110/ps.9.6.1162
29. Cuff JA, Clamp ME, Siddiqui AS, Finlay M, Barton GJ. JPred: a consensus secondary structure prediction server. Bioinformatics. 1998; 14: 892-893. http://dx.doi.org/10.1093/bioinformatics/14.10.892
30. Karplus K, Barrett C, Hughey R. Hidden Markov models for detecting remote protein homologies. Bioinformatics. 1998; 14: 846-856. http://dx.doi.org/10.1093/bioinformatics/14.10.846
31. Pollastri G, McLysaght A. Porter: a new, accurate server for protein secondary structure prediction. Bioinformatics. 2005; 21: 1719-1720. http://dx.doi.org/10.1093/bioinformatics/bti203
32. Jones DT. Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol. 1999; 292: 195-202. http://dx.doi.org/10.1006/jmbi.1999.3091
33. Adamczak R, Porollo A, Meller J. Accurate prediction of solvent accessibility using neural networks-based regression. Proteins. 2004; 56: 753-767. http://dx.doi.org/10.1002/prot.20176
34. Cheng J, Randall AZ, Sweredoski MJ, Baldi P. SCRATCH: a protein structure and structural feature prediction server. Nucleic Acids Res. 2005; 33: W72-W76. http://dx.doi.org/10.1093/nar/gki396
35. Horn F, Vriend G. G protein-coupled receptors in silico. J Mol Med. 1998; 76: 464-468. http://dx.doi.org/10.1007/s001090050240
36. Thompson JD, Higgins DG, Gibson TJ. Clustal-W - Improving the Sensitivity of Progressive Multiple Sequence Alignment through Sequence Weighting, Position-Specific Gap Penalties and Weight Matrix Choice. Nucleic Acids Res. 1994; 22: 4673-4680. http://dx.doi.org/10.1093/nar/22.22.4673
37. Galtier N, Gouy M, Gautier C. SEAVIEW and PHYLO_WIN: Two graphic tools for sequence alignment and molecular phylogeny. Comput Appl Biosci. 1996; 12: 543-548. http://dx.doi.org/10.1093/bioinformatics/12.6.543
38. Sali A, Blundell TL. Comparative Protein Modeling by Satisfaction of Spatial Restraints. J Mol Biol. 1993; 234: 779-815. http://dx.doi.org/10.1006/jmbi.1993.1626
39. Laskowski RA, Macarthur MW, Moss DS, Thornton JM. Procheck - a Program to Check the Stereochemical Quality of Protein Structures. J Appl Crystallogr. 1993; 26: 283-291. http://dx.doi.org/10.1107/S0021889892009944
40. Dastmalchi S, Morris MB, Church WB. Modeling of the structural features of integral-membrane proteins using reverse-environment prediction of integral membrane protein structure (REPIMPS). Protein Sci. 2001; 10: 1529-1538. http://dx.doi.org/10.1110/ps.6301
41. Bowie JU, Luthy R, Eisenberg D. A Method to Identify Protein Sequences That Fold into a Known 3-Dimensional Structure. Science. 1991; 253: 164-170. http://dx.doi.org/10.1126/science.1853201
42. Luthy R, Bowie JU, Eisenberg D. Assessment of Protein Models with 3-Dimensional Profiles. Nature. 1992; 356: 83-85. http://dx.doi.org/10.1038/356083a0
43. Dastmalchi S, Beheshti S, Morris MB, Church WB. Prediction of rotational orientation of transmembrane helical segments of integral membrane proteins using new environment-based propensities for amino acids derived from structural analyses. FEBS J. 2007; 274: 2653-2660. http://dx.doi.org/10.1111/j.1742-4658.2007.05800.x
44. Lindahl E, Hess B, van der Spoel D. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J Mol Mod. 2001; 7: 306-317. http://dx.doi.org/10.1007/s008940100045
45. Berendsen HJC, Postma JPM, Vangunsteren WF, Dinola A, Haak JR. Molecular-dynamics with coupling to an external bath. J Chem Phys. 1984; 81: 3684-3690. http://dx.doi.org/10.1063/1.448118
46. Tieleman DP, MacCallum JL, Ash WL, Kandt C, Xu Z, Monticelli L. Membrane protein simulations with a united-atom lipid and all-atom protein model: lipid-protein interactions, side chain transfer free energies and model proteins. J Phys Condens Matter. 2006; 18: S1221-S1234. http://dx.doi.org/10.1088/0953-8984/18/28/S07
47. Rivail L, Chipot C, Maigret B, Bestel I, Sicsic S, Tarek M. Large-scale molecular dynamics of a G protein-coupled receptor, the human 5-HT4 serotonin receptor, in a lipid bilayer. Theochem-J Mol Struct. 2007; 817: 19-26. http://dx.doi.org/10.1016/j.theochem.2007.04.012
48. Ungrin MD, Carriere MC, Denis D, Lamontagne S, Sawyer N, Stocco R, Tremblay N, Metters KM, Abramovitz M. Key structural features of prostaglandin E2 and prostanoid analogs involved in binding and activation of the human EP1 prostanoid receptor. Mol Pharmacol. 2001; 59: 1446-1456. http://www.ncbi.nlm.nih.gov/pubmed/11353805
49. Schüttelkopf AW, Van Aalten DMF. PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004; 60: 1355-1363. http://dx.doi.org/10.1107/S0907444904011679
50. Patny A, Desai PV, Avery MA. Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: Insights into the molecular determinants of telmisartan binding. Proteins. 2006; 65: 824-842. http://dx.doi.org/10.1002/prot.21196
51. Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. J Mol Graph. 1996; 14: 33-38. http://dx.doi.org/10.1016/0263-7855(96)00018-5
52. Wallace AC, Laskowski RA, Thornton JM. LIGPLOT - A program to generate schematic diagrams of protein ligand interactions. Protein Eng. 1995; 8: 127-134. http://dx.doi.org/10.1093/protein/8.2.127
53. Tramontano A. Homology modeling with low sequence identity. Methods. 1998; 14: 293-300. http://dx.doi.org/10.1006/meth.1998.0585
54. Shen MY, Sali A. Statistical potential for assessment and prediction of protein structures. Protein Sci. 2006; 15: 2507-2524. http://dx.doi.org/10.1110/ps.062416606
55. Stitham J, Arehart EJ, Gleim SR, Douville KL, Hwa J. Human prostacyclin receptor structure and function from naturally-occurring and synthetic mutations. Prostaglandins Other Lipid Mediat. 2007; 82: 95-108. http://dx.doi.org/10.1016/j.prostaglandins.2006.05.010
56. Kimura SR, Tebben AJ, Langley DR. Expanding GPCR homology model binding sites via a balloon potential: A molecular dynamics refinement approach. Proteins. 2008; 71: 1919-1929. http://dx.doi.org/10.1002/prot.21906
57. Stitham J, Stojanovic A, Merenick BL, O'Hara KA, Hwa J. The unique ligand-binding pocket for the human prostacyclin receptor: Site-directed mutagenesis and molecular modeling. J Biol Chem. 2003; 278: 4250-4257. http://dx.doi.org/10.1074/jbc.M207420200
58. Kedzie KM, Donello JE, Krauss HA, Regan JW, Gil DW. A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs. Mol Pharmacol. 1998; 54: 584-590. http://www.ncbi.nlm.nih.gov/pubmed/9730918
59. Audoly L, Breyer, RM. Substitution of charged amino acid residues in transmembrane regions 6 and 7 affect ligand binding and signal transduction of the prostaglandin EP3 receptor. Mol Pharmacol. 1997; 51: 61-68. http://www.ncbi.nlm.nih.gov/pubmed/9016347
60. Neuschafer-Rube F, Engemaier E, Koch S, Boer U, Puschel GP. Identification by site-directed mutagenesis of amino acids contributing to ligand-binding specificity or signal transduction properties of the human FP prostanoid receptor. Biochem J. 2003; 371: 443-449. http://dx.doi.org/10.1042/BJ20021429
61. Funk CD, Furci L, Moran N, Fitzgerald GA. Point Mutation in the 7th Hydrophobic Domain of the Human Thromboxane-a(2) Receptor Allows Discrimination between Agonist and Antagonist Binding-Sites. Mol Pharmacol. 1993; 44: 934-939. http://www.ncbi.nlm.nih.gov/pubmed/8246916
62. Audoly L, Breyer RM. The second extracellular loop of the prostaglandin EP3 receptor is an essential determinant of ligand selectivity. J Biol Chem. 1997; 272: 13475-13478. http://dx.doi.org/10.1074/jbc.272.21.13475
63. Rehwald M, Neuschafer-Rube F, De Vries C, Puschel GP. Possible role for ligand binding of histidine 81 in the second transmembrane domain of the rat prostaglandin F(2a) receptor. FEBS Lett. 1999; 443: 357-362. http://dx.doi.org/10.1016/S0014-5793(99)00007-1